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A B S T R A C T
Chlamydia trachomatis (Ct) is a human pathogen causing trachoma and infertility. We investigated
acetylation at lysine residues of chlamydial antigenic proteins: major outer membrane protein (MOMP),
60 kDa chaperonin (chlamydial Hsp60), elongation factor G (EF-G), enolase and the polymorphic
membrane proteins PmpB, PmpE and PmpF. 60 kDa chaperonin, EF-G and PmpB showed the highest
degree of acetylation.
Our data show that important Ct antigens could be post-translationally modified by acetylation of
lysine residues at multiple sites. Further studies are needed to investigate total acetylome of Ct and the
impact PTMs might have on Ct biology and pathogenicity.
ã 2016 The Authors. Published by Elsevier B.V. on behalf of European Proteomics Association (EuPA). This
is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Contents lists available at ScienceDirect
EuPA Open Proteomics
journal homepa ge: www.elsev ier .com/locate /euprot1. Introduction
Chlamydia trachomatis (Ct) is an obligate intracellular pathogen
causing socioeconomically significant morbidities as blindness
(trachoma) and female infertility [1]. Ct species is divided into
three biovars and various serovars that differ in their major outer
membrane proteins and are associated with a number of diseases.
Serovars A, B, Ba and C are considered ocular strains, serovars D–K
cause sexually transmitted diseases worldwide, and serovars L1–
L3 inflict severe systematic infection lymphogranuloma venereum
[2]. Factors that contribute to chlamydial pathogenicity and
persistence in tissues are still not fully understood. Proteomic
approaches could help elucidate involved mechanisms, since post-
translational modifications (PTMs) and level of protein expression
are taken into account – categories otherwise frequently under-
estimated or overlooked in transcriptomics and genomics studies.
In order for an organism to survive and thrive in ever changing
and hostile environments it needs flexible survival mechanisms.
PTM of proteins is a strategy that organisms employ to control their* Corresponding author at: Center of Excellence for Molecular Food Sciences and
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Some of the most studied PTMs include phosphorylation (Ser, Thr,
Tyr), ubiquitination and sumoylation (Lys), methylation (Arg, Lys)
and acetylation (Lys) [3].
Acetylation of lysine is an important, functional PTM that in
eukaryotes, among many significant regulatory mechanisms, also
affects cell cycle and tumour suppression through activation of
p53 by acetylation of its distinct lysine residues. It occurs on the
e-amino group of lysine, and it is one of the easiest PTM sites to
identify, due to the 42 Da mass shift (resulting from the
replacement of one of the hydrogens from the amine group with
COCH3) on the modified amino acid. It is a dynamic process
performed by acetyl transferases, while the reverse is performed
by deacetylases. Until recently it was thought to occur only in
eukaryotes, but emerging data suggest that it occurs in prokaryotes
as well [4]. Moreover, this reversible process enables some
bacterial species to regulate cellular processes, infect, survive
and even thrive in hostile environments [5]. Whether there are
post-translationally acetylated lysine Ct antigenic proteins is
unknown, as well as their impact and role within pathobiology
of Ct.
Lysine acetylation could affect Ct infectious potential and
pathogenicity and also alter the immunogenicity of Ct proteins. “If”
and “how” need to be answered in order to help reveal the role of
specific antigens in immunopathology and protection. Many
immunological studies on Ct, mainly on genital and lesser on
ocular serovars, have identified several major antigens elicitingics Association (EuPA). This is an open access article under the CC BY license (http://
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antigens include a serotyping agent like the major outer membrane
protein (MOMP) [6], polymorphic membrane proteins (Pmps) and
chlamydial Hsp60 (cHsp60; known as GroEL and 60 kDa chaper-
onin) associated with Ct pathology and other dominant antigens
from cytosol with an unknown role, as highly conserved metabolic/
modifying and general secretion pathway enzymes [7]. Within this
complex story of Ct pathologies, we have recently undertaken a
quantitative immunoproteomic and chemometrics study of ocular
Ct serovar B (CtB) and its severe trachoma relevant antigen
characterization raising IgG response within 2 endemic African
country populations at the stage of trachoma-caused blindness
(data unpublished). There are no proteomic studies on ocular
serovar B and consequently no immunoproteomic research with
human trachoma patients and CtB immunodominant antigens, at
this point.
Based on this immunoproteomic study, we have selected for our
current preliminary research on the existence of Ct proteins’ lysine
acetylation, 5 most impactful major antigens, that have the highest
influence on endemic trachoma patients and healthy control
differentiation with significantly higher or exclusive IgG response
in trachoma patients elicited by: MOMP, cHSP60), elongation
factor G (EF-G), enolase and PmpF. Additionally, lysine acetylation
of PmpB as pelvic infection disease dominant antigen [8] and PmpE
as promising vaccine candidate for genital disease model [9], were
also selected for examination. Out of the seven selected proteins,
MOMP, 60 kDa chaperonin and Pmps have been characterized as
major (dominant) Ct antigens in all serovars (ocular, genital and
LGV) [1].
In this study we assessed three biological samples obtained at
different time points of CtB with the gel-aided shotgun
proteomics as a model to investigate the acetylation pattern of
seven important CtB antigens: MOMP, 60 kDa chaperonin, EF-G,
enolase, PmpB, PmpE and PmpF, that has been supported by
Western blot of CtB proteome probed with anti-acetylated lysine
specific antibody.
2. Materials and methods
2.1. Ct growth conditions and EBs purification
CtB (ATCC1 VR-573TM) were propagated in McCoy cells (ATCC1
CRL-1696TM, passages varying from P3 to P26) according to
standard procedures [10]. Harvested stocks were centrifuged at
200  g to pellet cellular debris. To purify EBs supernatants were
layered over discontinuous Renografin gradients as described by
Caldwell et al. [11]. The resulting EB fraction was washed twice in
0.01 M sodium phosphate (pH 7.2) containing 0.25 M sucrose and
5 mM L-glutamic acid (SPG). Pellets were resuspended in SPG and
stored at 80 C until analysis. For heat-inactivation samples were
incubated at 56 C for 30 min.
2.2. Electrophoresis
SDS-PAGE was carried out according to Laemmli [12] using a
Hoefer scientific instrumentation apparatus (Amersham Bioscien-
ces, USA) with a discontinuous buffer system. Protein components
were resolved on 12% polyacrylamide gels (PAA), which were
stained using Coomassie Brilliant Blue R-250 (Sigma–Aldrich,
Germany).
2.3. Western blot
CtB lysate (20 mg/lane) was resolved on 12% PAA and
subsequently transferred to a nitrocellulose membrane, 0.2 mm
(Bio-Rad, Germany) by blotting according to Towbin et al. [13]using BlueFlashTM Semi-Dry Blotter (Serva electrophoresis,
Germany). The membrane was blocked with 1% bovine serum
albumin (BSA) and probed with commercial anti-acetyl lysine IgG
developed in rabbit (Abcam, ab80178) in 1:1000 dilution. BSA
solution (0.5%) was used instead of primary antibody as a control.
Western blot was developed using alkaline phosphatase conjugat-
ed goat anti rabbit IgG (Jackson ImmunoResearch, 111-055-045) in
1:1000 dilution, as a secondary antibody. The phosphatase activity
was visualized using 5-bromo-4-chloro-3-indolyl phosphate
(BCIP) and nitroblue tetrazolium (NBT). Imaging and analyses of
the immunoblot bands were performed by laser Typhoon
7000 series scanner and Image Quant TL 7.0 software (GE
Healthcare, USA). The procedure is explained in Supplementary
data.
2.4. Shotgun proteomics of CTB antigens
2.4.1. Bands excision and preparation for MS
CtB preparations (4 mg, 8 mg and 14 mg) corresponding to
3 biological batches of CtB were electrophoretically resolved on a
12% polyacrylamide gel. After colloidal CBB staining bands from all
resolved preparations were excised and in gel digested according
to Shevchenko et al. [14]. Briefly, in-gel digestion procedure is
compatible with downstream nano-LC–MS/MS characterization of
digests derived from protein bands. When complex protein
mixtures are gel-separated and analyzed by LC–MS/MS, the in-
gel digestion procedure enables the analysis of entire proteomes of
organelles and the majority of proteins in cell lysates. First step is
band excision from the gel with a surgical scalpel. After washing
with 25 mM ammonium bicarbonate buffer (ABC) and solution of
50% acetonitrile with 25 mM ABC in order to eliminate contam-
inants related to gel dying, the protein bands were treated with
10 mM DTT to reduce disulphide bridges. Afterwards, bands were
alkylated with 55 mM iodoacetamide to block cystein residues and
prevent re-formation of disulphide bonds. Proteins in gel bands
were digested overnight at 37 C with 10–20 mL of 15 ng/mL trypsin
(proteomics grade, Sigma, Germany) applied per band depending
on its size (the square area range of the band treated was 5–
10 mm2). Peptide mixtures were filtered by zip tips prior to MS
analysis.
2.4.2. Nano-LC–MS/MS
All excised and digested bands were analyzed by LC–MS/MS.
Peptides were chromatographically separated using the EASY-
nLC II system (Thermo, Germany) with a 2 column set up: trap
column C18-A1, 2 cm (Thermo, Germany) and analytical column
PepMap C18, 15 cm  75 mm, 3 mm particles, 100 Å pore size
(Thermo, Germany). Mobile phases used were A: 0.1% formic acid
in water and B: 0.1% formic acid in acetonitrile. All solvents
used were MS grade (Sigma, Germany). Total of 2 mL of each
sample was loaded and separated by a gradient over the course of
80 min with a flow rate of 300 nL/min. The flow gradient was (i)
0–5 min at 5% B, (ii) 5–55 min, 5–70% B, (iii) 55–60 min 70–95%
B, (iv) 60–70 min 95% B, (v) 70–75 min 95–5% B, (vi) 75–80 min
5% B.
Peptides were analyzed by LTQ Orbitrap XL mass spectrometer
in data dependent mode with nano-ESI spray voltage of 1.9 kV,
capillary temperature of 275 C and tube lens value set at 110 V. All
spectra were acquired in positive mode with high-resolution full
scan in the mass range m/z 300–2000 and Orbitrap resolution of
30,000. The 5 most intense precursors were subjected to collision
induced dissociation (CID) with normalized collision energy of
35 and activation time of 30 ms. Dynamic exclusion with 1 repeat
count over 10 s and exclusion for 10 s was applied.
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search
Identification of chlamydial proteins was performed by
Proteome discoverer 1.3 (Thermo, Germany) and PEAKS Studio
7.5 (Bioinformatics Solutions Inc., Canada). Signature MS/MS
spectra were searched by SEQUEST and PEAKS DB algorithms
against Uniprot (Swiss-Prot + trEMBL) derived Ct protein database
(downloaded on 30/09/2015 from http://www.uniprot.org/).
Database contained 40536 sequences, both reviewed and unre-
viewed. Carbamidomethylation (Cys) as fixed, while acetylation
(Lys), oxidation (Met) and deamidation (Gln, Asn) were taken into
account as potential modifications, incomplete cleavage (up to
4 missed cleavage sites) and well as peptide FDR of 0.1–5% was
allowed. Tolerance was set at 0.8 Da for peptides and at 10 ppm
fragments, “Decoy” was enabled. Spectra acquired from all gel
slices were processed as a contiguous input file resulting in a single
report file. Only protein hits with SEQUEST score higher than 10, at
least 2 high confidence peptides and at least one unique peptide,
were searched for lysine acetylation. All MS/MS spectra of Lys-
acetylated candidates were manually checked for predicted lysine
site(s).
3. Results and discussion
3.1. Shotgun proteomics of CtB reveals a plethora of protein identities
inferred from homology with other Ct serovars
CtB grown in McCoy cells (mouse fibroblasts [15]) were
harvested between 3rd and 26th passage, EBs were purified and
lysates were prepared for protein analysis. Lysates of CtB EB
analysed by SDS PAGE showed different protein patterns especially
lane C, compared to lanes A and B that share a high degree of
similarity (Fig. 1). Dissimilarities in protein profiles, beside
different quantities applied, are attributed to variation in protein
expression levels depending on cell cycle phase of CtB duringFig. 1. Electrophoretic profile of heat inactivated CtB protein preparations on 12%
PAA gel in reducing conditions that were subjected to shotgun proteomics. Each
preparation is assigned a label: A-4 mg, B-8 mg, C-14 mg. Abbreviations: MW =
molecular weight markers.purification [16]. All three chlamydial forms (elementary, reticu-
late and intermediate bodies) are present in different ratios in
infected cells [16]. “Contamination” by non-EB proteins could also
account for differences in preparations. Contamination due to
difficulties in purification of chlamydial proteins is also possible
and could be the main reason for differences observed in the profile
of lane C. The release of EBs results in rupture of host cells [2] and
purifying it from host cellular debris can result in contamination by
non-chlamydial proteins, in this case by mouse fibroblast proteins.
Indeed, preliminary SwissProt database search (data not shown)
on this particular CtB lane revealed minor to moderate presence of
mouse fibroblast proteins.
All electrophoretically resolved CtB EB lysates (Fig. 1) were cut
into bands (Supplementary data, Fig. E1) and subjected to trypsin
digestion prior to mass spectrometry analysis. Upon Uniprot
derived Ct database search by SEQUEST, 263 protein hits were
matched as chlamydial proteins (Supplementary data, Table E1)
with 4 missed cleavages and 5% FDR allowed. PEAKS DB algorithm
found 239 hits (Supplementary data, Table E2) under the same
conditions. With very strict FDR of 0.1% at peptide level SEQUEST
found 125 chlamydial protein hits (Supplementary data, Table E3),
while PEAKS DB found 190 hits (Supplementary data, Table E4). We
have identified a number of proteins involved in cellular processes
– isomerases, kinases, mutases, chaperone proteins; proteins
involved in translation and replication – 30S and 50S ribosomal
proteins, elongation factors (G, P, Ts and Tu), DNA polymerases,
helicases and a gyrase; a number of transcription factors and a
number of CtB envelope proteins – MOMP, Pmps and type III
secretory system proteins (Supplementary data, Table E1–E4). It is
interesting to note that great majority of these identifications is
based on homology to other serovars as A, L2 and L2b. Only MOMP
identification resulted in CtB taxon even though genomes of two
strains of CtB were recently sequenced and annotated: strain B/
TZ1A828/OT and Jali 20 (http://www.sanger.ac.uk/resources/). The
strain we studied is trachoma type B strain HAR-36, and it would be
worth undertaking a de novo analysis via PEAKS de novo algorithm
to search for sequence differences in homologue proteins between
serovars and their possible effects on different aspects of Ct
pathobiology.
3.2. CtB major trachoma antigens (MOMP, PmpF, cHsp60, EF-G,
enolase) and PmpB and PmpE show different lysine acetylation
patterns
Out of all identified proteins we have selected 7 proteins to
assess for the existence of lysine acetylation PTM within CtB
proteome. This selection of lysine acetylated (AcK) CtB candidates,
as previously elaborated, was mostly based on the results of our
immunoproteomic study (unpublished data) with patients from
Sudan and Ethiopia suffering from trachomatous trichiasis and
their matched controls. This study revealed 35 major, trachoma
relevant antigens (present in more than 50% of patients per group).
Out of this antigenic pool influencing diseased and control group
segregation, we have selected 5 most impactful major antigens
with various functional and localization properties. Additional two
proteins (PmpB and PmpE) were selected as major genital Ct
antigens [8,9,17], since the relevance of Ct acetylated proteins’
subject is beyond serovars’ differentiation. Beside genomics
profiling reports as minor genital antigenic candidate, EF-G [18]
and enolase as chlamydial T cell reactive antigen [19], neither has
been assigned a major Ct antigen attribute as suggested by our
immunoproteomic trachoma study. In addition to being chlamyd-
ial antigens, EF-G, enolase and 60 kDa chaperonin are well
characterized as acetylated proteins across bacterial species [5].
Proteins we have chosen to investigate for acetylation are either
located in the bacterial envelope like MOMP [20] and Pmps [21] or
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enolase could be expressed in the bacterium surface as well [22].
Functionally they cover involvement in housekeeping mechanisms
– enolase [23], protein synthesis – EF-G [24] or folding—60 kDa
chaperonine [25]. Pmps are specific outer membrane proteins
whose precise functions remain unknown, but they have been
implicated in pathogenesis and host cell adherence [17].
No enrichment of acetylated peptides was performed at this
stage, so in order to detect as many acetylations as possible (within
the chosen 7 proteins) we searched for the PTMs within SEQUEST
search results with up to 4 missed cleavages allowed and peptide
FDR of 5% (Tables 1 and 2). To confirm the presence of lysine
acetylation each MS/MS spectrum was checked for presence of a
fragment containing the PTM in question. Every candidate’s
fragment spectrum was manually curated for lysine acetylation
and only those with experimental data confirmation but not
theoretical prediction data were accepted as true lysine acetylation
sites (representative fragmentation spectra are represented in
Supplementary data, Fig. E2–E9).
60 kDa chaperonin, EF–G and PmpB showed the highest degree
of acetylation out of the inspected proteins with 13, 12 and 9
acetylation sites respectively (Table 1). PmpE and PmpF are hexa-
acetylated, while MOMP and enolase show only 4 and 3
acetylations, respectively (Table 1).
Observing acetylation patterns at peptide level (Table 2) a total
of 2 peptides with 3 acetylated lysines have been detected, which
belong to PmpB and PmpF. Out of 43 confirmed acetylated
peptides, 7 are diacetylated, while 34 have only one acetylation site
(Table 2). Most peptides have a charge of 2 or 3 (22 and 16,
respectively), while there are only 5 peptides with a charge of 4
(Table 2).
MOMP is the primary chlamydial serotyping antigen and the
most abundant protein in Ct proteome, comprising of up to 30% of
its content [11]. This molecule contains antigenic determinants
eliciting serovar-, subspecies-, serogroup-, and species-specific
antibodies [26],[27]. We have found 4 acetylation sites in MOMP
(Tables 1 and 2), and so far there are no published MOMP dynamic
acetylation data we could compare our findings to. Worthy to note
here is that MOMP represents one of the most impactful CtB
antigens responsible for the trachoma patients’ differentiation
from matched controls according to our unpublished data.Table 1
Sequest identification of 7 acetylated CtB antigens (peptide FDR 5%).
Accession Protein description Sco
P23421 Major outer membrane porin, serovar B OS = Chlamydia trachomatis
GN = ompA PE = 2 SV = 1  [MOMPB_CHLTH]
558
Q3KMQ9 60 kDa chaperonin OS = Chlamydia trachomatis serovar A (strain
ATCC VR-571B/DSM 19440/HAR-13) GN = groL PE = 2 SV = 3 
[CH60_CHLTA]
244
G4NNI1 Elongation factor G OS = Chlamydia trachomatis serovar A (strain
A2497) GN = fusA PE = 3 SV = 1  [G4NNI1_CHLT4]
15
O84591 Enolase OS = Chlamydia trachomatis (strain D/UW-3/Cx) GN = eno
PE = 3 SV = 1  [ENO_CHLTR]
14
Q2TGM5 Polymorphic membrane protein B OS = Chlamydia trachomatis
GN = pmpB PE = 4 SV = 1  [Q2TGM5_CHLTH]
17
Q2TGH5 Polymorphic membrane protein F OS = Chlamydia trachomatis
GN = pmpF PE = 4 SV = 1  [Q2TGH5_CHLTH]
12
Q84FV6 Polymorphic membrane protein E (Fragment) OS = Chlamydia
trachomatis GN = pmpE PE = 4 SV = 1  [Q84FV6_CHLTH]
9
Abbreviations: Cov. = protein sequence coverage, Pep. = peptide, # Uniq. Pep. = num
matches.Whether MOMP’s acetylation plays a role in this remains to be
established.
Pmps are chlamydia specific proteins, located in the bacterial
envelope involved in chlamydial attachment to human epithelial
and endothelial cells. Pmps A–I are auto-transporter proteins with
an N-terminal part exposed on the surface of the bacteria or
secreted, thus being promising vaccine candidates [28]. In
connection to that, the polymorphic membrane protein family
A–I have shown favourable attributes as vaccine components as
they are dominant antigenic targets for cellular immune responses
[7,17]. Proteins belonging to this family have been known to
undergo infection-dependent post-translational modifications
[17]. Similar to MOMP, this is the first study investigating Pmp
acetylation. Out of nine members of this family, we have chosen
PmpB, PmpE and PmpF for the determination of acetylation sites,
and have found 9, 6 and 6 of them respectively. Being at the hotspot
of “immunological paradigm” of Ct research and Ct vaccine
development, high degree and pattern of Pmps acetylation warrant
further, immediate investigation. Recent comprehensive bioinfor-
matic study of Nunes et al. [17] demonstrated that PmpE, PmpG,
PmpF and PmpH are the most suitable protective Ct antigenic
candidates and that their certain combination in vaccine compo-
sition could overcome immune selection of phase variants and
low/high polymorphism. PTM such as AcK and in such a high
extent as found in PmpE and PmpF, introduces a new level of
diversity mimicking “polymorphism” and should be taken into
account when examining vaccine immunogenicity, specificity and
safety.
Enolase is a well-known, conserved protein, present across
prokaryotic and eukaryotic species. It is categorized as a cytosolic
metalloenzyme, with a key role in fermentation and glycolysis
(catalysis of the reversible conversion of 2-phospho-D-glycerate
to phosphoenolpyruvate) [23]. It is one of the most abundantly
expressed cytoplasmic proteins in many organisms, being also
present on the bacterial surface in many pro- and eukaryotic
organisms [22]. Besides enolase’s well-studied metabolic func-
tion, it moonlights as plasmalogen, fibronectin and laminin
binding protein [29] being thus involved in pathogenic and
virulence mechanisms [30]. According to published data enolase
is not a highly acetylated protein in bacteria, with 1 acetylation
site found in Bacillus subtilis [31] and Escherichia coli [32]. Ourre Cov.
(%)
#
Uniq.
Pep.
#
Pep.
#
PSMs
MW
(kDa)
calc.
pI
# AC
sites
AC positions
8.16 77.92 8 35 3684 42.5 5.34 4 75, 80, 87, 353
8.06 86.21 30 103 2079 58.1 5.35 13 15, 18, 34, 75, 80, 125,
133, 142, 322, 327, 350,
371, 462
6.39 79.77 6 74 367 77.4 5.34 12 48, 134, 145, 266, 279,
290, 490, 508, 511, 540,
690, 694
1.08 46.23 6 25 170 45.4 4.73 3 192, 193, 398
1.94 41.18 7 91 575 182.9 6.02 9 302, 313, 491, 1174,
1175, 1181, 1512, 1518,
1605
5.85 47.58 6 58 263 112.7 8.43 6 17, 123, 243, 323, 422,
714
9.36 40.86 3 39 180 101.7 7.53 6 819, 821, 868, 869, 872,
1003
ber of unique peptides, AC = acetylation, # PSMs = number of peptide-spectrum
Table 2
Sequest identification of 43 acetylated peptides from 7 CtB antigens (peptide FDR 5%).
Peptide sequencea #
PSMs
Modifications Number
of AC
sites
DCn XCorr Charge MH+
[Da]
DM
[ppm]
RT
[min]
# Missed
Cleavage
sites
Protein description
VLK*TDVnKEFqMGAKPTTTTGnAVAPSTLTAR 6 K3(Acetyl); N7(Deamidated); Q11
(Deamidated); N22(Deamidated)
1 0.000 2.67 4 3392.73 2.21 32.23 2 P23421 Major outer membrane porin, serovar B OS =Chlamydia
trachomatis GN=ompA PE=2 SV=1 [MOMPB_CHLTH]
TDVnK*EFqMGAKPTTTTGNAVAPSTLTARb 71 K5(Acetyl); N4(Deamidated); Q8
(Deamidated)
1 0.000 4.01 3 3051.52 8.86 24.12 1
TDVNKEFQMGAK*PTTTTGnAVAPSTLTAR 5 K12(Acetyl); N19(Deamidated) 1 0.156 1.90 4 3050.51 0.03 31.30 1
EFQmGAK*PTTTTGNAVAPSTLTAR 3 K7(Acetyl); M4(Oxidation) 1 0.000 1.94 3 2508.24 0.21 24.33 0
TSAEGQLGDTMQIVSLqLNKMK*SRb 3 K22(Acetyl); Q17(Deamidated) 1 0.286 1.82 3 2678.37 9.27 34.18 2
K*IQK*GVK 3 K1(Acetyl); K4(Acetyl) 2 0.191 1.10 2 884.56 0.87 15.63 2 Q3KMQ9 60kDa chaperonin OS =Chlamydia trachomatis serovar A
(strain ATCC VR-571B/DSM 19440/HAR-13) GN=groL PE= 2
SV=3 [CH60_CHLTA]
VTLGPK*GR 1 K6(Acetyl) 1 0.188 1.08 2 869.52 2.18 27.75 1
HENmGAQmVK*EVASK*TADK 1 K10(Acetyl); K15(Acetyl); M4
(Oxidation); M8(Oxidation);
2 0.290 1.52 3 2190.04 9.85 37.39 2
GIDKAVK*VVVDqIKb 2 K7(Acetyl); Q12(Deamidated) 1 0.175 1.41 2 1554.91 1.17 37.18 2
AVKVVVDQIK*K 2 K10(Acetyl) 1 0.283 0.43 2 1268.79 3.63 48.10 2
KISKPVQHHK* 1 K10(Acetyl) 1 0.100 0.45 2 1243.74 6.45 70.29 1
AKK*VIVSK* 3 K3(Acetyl); K8(Acetyl) 2 0.111 1.12 3 956.61 1.01 22.23 2
EALEARcESIK*K 14 K11(Acetyl); C7(Carbamidomethyl) 1 0.155 1.42 2 1475.75 3.78 34.00 2
LAK*LSGGVAVIR 2 K3(Acetyl) 1 0.369 0.53 2 1225.77 2.28 58.62 1
QIAANAGK* 3 K8(Acetyl) 1 0.435 0.83 2 814.44 0.93 19.21 0
THK*IGEVHEGGATmDWMEQEQER 3 K3(Acetyl); M14(Oxidation) 1 0.000 0.98 4 2756.18 9.32 19.86 1 G4NNI1 Elongation factor G OS =Chlamydia trachomatis serovar A
(strain A2497) GN= fusA PE= 3 SV=1 [G4NNI1_CHLT4]QANK*YGVPR 1 K4(Acetyl) 1 0.179 1.38 3 1074.58 8.57 18.96 1
IAFVnK*MDR 1 K6(Acetyl); N5(Deamidated) 1 0.062 0.91 3 1136.58 6.19 29.56 1
KGVIEGK* 2 K7(Acetyl) 1 0.000 1.28 2 772.46 1.38 30.43 1
NK*GVqqLLDVIVK*WLPSPLDR 3 K2(Acetyl); K13(Acetyl); Q5
(Deamidated); Q6(Deamidated)
2 0.360 1.37 3 2504.35 8.95 44.40 2
VEANVGK*PQVSYK 1 K7(Acetyl) 1 0.161 0.99 2 1460.77 1.81 35.24 0
TSnSETK*YVK 1 K7(Acetyl); N3(Deamidated) 1 0.230 0.67 2 1199.57 7.04 46.70 1
YVK*qSGGR 1 K3(Acetyl); Q4(Deamidated) 1 0.000 1.02 2 937.48 1.63 20.35 1
GnEVVSK*IVGGVIPKb 1 K7(Acetyl); N2(Deamidated) 1 0.110 1.86 2 1538.88 1.29 39.38 1
ATSTMEPAFFAK*VPqK*IqEEIVK 1 K12(Acetyl); K16(Acetyl); Q15
(Deamidated);Q18(Deamidated)
2 0.128 1.23 3 2678.38 7.39 34.41 2
MGAEVFnALK*K 1 K10(Acetyl); N7(Deamidated) 1 0.312 0.75 2 1250.64 4.25 27.03 1 O84591 Enolase OS=Chlamydia trachomatis (strain D/UW-3/Cx)
GN=eno PE= 3 SV=1 [ENO_CHLTR]mGAEVFNALKK* 5 K11(Acetyl); M1(Oxidation) 1 0.000 1.53 2 1265.64 10.01 47.75 1
SERIAK*YnRb 1 K6(Acetyl); N8(Deamidated) 1 0.210 1.09 2 1179.60 7.31 39.66 2
ATKDGGAIFA EK*DVSFEnIT SLK*VQTnGAEEK 1 K12(Acetyl); K23(Acetyl); N18
(Deamidated); N27(Deamidated)
2 0.248 1.61 3 3483.69 2.70 53.78 3 Q2TGM5 Polymorphic membrane protein B OS =Chlamydia
trachomatis GN=pmpB PE=4 SV=1 [Q2TGM5_CHLTH]
NSSDK*QGGGIYGEDNITLSNLTGKTLFqENTAK 14 K5(Acetyl); Q28(Deamidated) 1 0.000 2.05 3 3543.73 7.21 42.59 2
GKTISFFDcVHTSTK*K*TGSTQK*VYETLDINK 1 K15(Acetyl); K16(Acetyl); K22(Acetyl);
C9(Carbamidomethyl)
3 0.000 1.49 3 3659.82 2.67 39.65 4
QDFILGAAFSK*MVGKTKAIK*K 2 K11(Acetyl); K20(Acetyl) 2 0.436 1.37 3 2365.34 1.86 41.67 4
ISMDLK*EPSKb 1 K6(Acetyl) 1 0.168 1.74 2 1189.60 9.27 32.75 1
ESLSnK*ISLTGDTHNLTncYLnNLR 3 K6(Acetyl); N5(Deamidated); N18
(Deamidated); C19(Carbamidomethyl);
N22(Deamidated)
1 0.328 1.58 4 2922.36 5.13 41.59 1 Q84FV6 Polymorphic membrane protein E (Fragment)
OS=Chlamydia trachomatis GN=pmpE PE=4
SV=1 [Q84FV6_CHLTH]
nPYAAANK*IR 1 K8(Acetyl); N1(Deamidated) 1 0.621 0.77 2 1160.60 4.95 23.62 1
GNIVFYNnRcFK* 1 K12(Acetyl); N8(Deamidated); C10
(Carbamidomethyl)
1 0.310 0.89 3 1574.74 2.04 22.82 1
GGAIYIDGTSnSK*ISADRb 1 K13(Acetyl); N11(Deamidated) 1 0.006 1.65 3 1867.92 7.09 36.69 1
NLQTK*TPATLTLnHGFLcIEDRAQLAVnR 7 K5(Acetyl); N13(Deamidated); C18
(Carbamidomethyl); N28(Deamidated)
1 0.246 2.24 4 3338.75 8.46 37.52 2
FSQTYTK*LNERYAK 1 K7(Acetyl) 1 0.000 0.67 2 1790.89 7.94 60.57 2
FLLSFSQSSDKMK*EKETNNR 1 K13(Acetyl) 1 0.316 0.65 2 2431.20 1.46 41.84 3 Q2TGH5 Polymorphic membrane protein F OS =Chlamydia
trachomatis GN=pmpF PE=4 SV=1 [Q2TGH5_CHLTH]mKEK*ETnnR 2 K4(Acetyl); M1(Oxidation); N7
(Deamidated); N8(Deamidated)
1 0.280 0.95 3 1209.54 0.33 12.66 2
SFYGTK*K*SSK*GK 1 K6(Acetyl); K7(Acetyl); K10(Acetyl) 3 0.069 1.21 2 1485.76 2.11 35.09 3
GSHSLK*FSHLKb 1 K6(Acetyl) 1 0.041 1.42 2 1282.69 0.99 36.13 1
Abbreviations: AC= acetylation, # PSMs=number of peptide-spectrum matches.
a Acetylated lysine residues are indicated by asterisk (*), while all other AA residue modifications are indicated by lower case letters (m, n, q).
b Spectra figures shown in Supplementary data (Fig. E2–E9).
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Fig. 2. Detection of lysine acetylated proteins from CtB. (A) Ponceau S stain of NC
membrane showing full CtB lysate; (B) Western blot probed with commercial
acetylated lysine-specific primary antibody, and secondary alkaline phosphatase
conjugated anti-rabbit antibody. (C.) Acetylated CtB band detection by Image Quant
TL software.
68 J. Mihailovic et al. / EuPA Open Proteomics 10 (2016) 63–69study indicates CtB enolase has 3 acetylated lysine residues which
is surprising due to the high degree of sequence homology within
bacterial enolase isoforms. Sequence similarities between CtB
enolase and human counterpart are also relatively high. Aligning
identified CtB enolase (Accession: O84591) with human a-enolase
isoform (Accession: P06733) in Clustal Omega at www.uniprot.
org, showed a sequence similarity of 47% (208 amino acid
residues-AA) with additional 123 similar AA positions and
identical peptides 11 AA long. This almost definitely precludes
enolase as a vaccine candidate, since high sequence homology can
be the cause of immunopathology as seen with cHSP60 and Ct
infection. Based on this, our finding of triply acetylated enolase
speaks in favour of importance of PTM machinery in creating
additional diversity.
cHSP60 is a rather controversial antigen, being connected to
both, human immunopathology and protection [33,34]. It has a
highly conserved sequence among bacteria and is also involved in
human immunopathology in ocular and genital diseases [33,35]. It
was shown by Peeling et al. that cHsp60 is associated with
trachomatous scarring in 32% of tested Gambian trachoma patients
[36] but there are also studies showing opposite protective effects
[37,38]. Using proteomics tools we have identified 13 acetylation
sites which is in accordance with findings for Thermus thermophilus
(12 sites), Mycobacterium tuberculosis and Pseudomonas aeruginosa
(13 sites each) [5]. Parallel to that, and in accordance with cHSP60
role in both immunopathology and protection, our immunopro-
teomic data (unpublished), point to cHSP60 being a major antigen
that equally well separates all diseased subjects from all healthy
controls and all Sudanese from all Ethiopians, being a disease and
country specific antigenic marker.
EF-G is a GTP-dependent five domain effector that promotes
directional movement of mRNA and tRNAs on the ribosome [39].
EF-G is a well-studied Ct antigen [1] and a universally conserved
bacterial GTPase [40]. In our study EF-G stands out as one of the
most acetylated proteins, with 12 acetylated lysine residues
found. There is a need for further investigation to shed light on
this result in connection to the finding that EF-G is a relevant
severe trachoma major antigen eliciting solely an IgG response in
diseased subjects from both countries and almost none in their
matched controls.3.3. Anti-acetyllysine specific antibody immunoblot on CtB proteome
reveals many lysine acetylated protein bands and confirms selected
trachoma major antigens as acetylated
Western blot of CtB proteome probed with specific anti-
acetylated lysine antibody showed over a dozen of specific lysine
acetylated protein bands including also those with molecular
masses corresponding to the above mentioned 5 major CtB
antigens (Fig. 2 and Supplementary data Fig. E10), with the two
most intense bands at 17 and 30 kDa belonging possibly to various
ribosomal proteins and urydilate kinase enzyme, as inferred from
the immunoproteomics results from our parallel study (unpub-
lished). Immunoblotting studies showed that CtB proteins contain
acetylated lysines when grown in McCoy cells (Fig. 2 and
Supplementary data Fig. E10) and also demonstrated specificity,
since there are no corresponding bands in conjugate controls as
analyzed by Image Quant TL software. Sixteen acetylated proteins
were detected (Fig. 2. and Supplementary data Fig. E10) that
ranged in size from 14 kDa to 130 kDa. This finding besides its
confirmatory role for the big part of selected AcK protein
candidates, also demonstrates that there are far more acetylated
CtB proteins than our initial selection. Regarding the PmpB and
PmpE that were not recognized as trachoma relevant antigens in
our immunoproteomic study (unpublished) we could not observe
their full length protein bands as acetylated and there is a
possibility that they are present as fragments as there are faint
bands at approximately 130 and 80 kDa [8].
Besides major bands, in anti-acetylated lysine probed blot,
there are also many weakly recognized bands showing diversity of
lysine acetylation that were below Western blot limit of detection.
Both approaches applied in our study aim at detecting the most
abundant as well as the most prominently acetylated proteins of
CtB. On the other hand, due to regulatory role of lysine acetylation,
many proteins undergo this PTM in various stages of bacterium’s
life cycle. Therefore, for an in depth study of the total CtB
acetylation pattern, additional experiments involving enrichment
of the acetylated fraction with anti-acetylated lysine antibodies are
warranted.
4. Conclusions
Here we present for the first time that lysine acetylation is
frequent in important CtB antigens. Acetylation of lysine residues
could alter the conformation as well as the immunogenicity of
antigens, which is of the utmost importance for further
understanding of chlamydial biology and vaccine development.
It can also be of importance in clarifying yet unresolved
mechanisms of Ct pathogenicity. Our data suggest that important
Ct antigens could be post-translationally modified by acetylation of
lysine residues at multiple sites. For a better understanding of Ct
pathology and selection of suitable antigen candidates for Ct
vaccine development, total acetylome of Ct should be further
investigated by MS-based strategies that also involve enrichment
of modified proteins by immunoprecipitation.
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